Amcor PLC vs Danaher Corporation — how do they compare? Amcor PLC trades at $46.39 (market cap $21.53B), while Danaher Corporation trades at $203.89 (market cap $144.67B). The key difference: Danaher Corporation is far larger — about 6.7× Amcor PLC's market cap, and Amcor PLC pays the higher dividend (5.58%). Which is the better fit depends on your goals.
| AMCR | DHR | |
|---|---|---|
Market Cap | $21.53B | $144.67B |
Sector | Basic Materials | Health |
52-Week High | $50.58 | $242.05 |
52-Week Low | $36.69 | $161.91 |
Enterprise Value | $34.42B | $166.88B |
Dividend Yield | 5.58% | 0.78% |
Signals from Pluang's Aura AI — not financial advice
AMCR trades at $46.38, down 2.15% today, with a bullish technical signal from moving averages and neutral oscillators. The stock shows strong earnings beats in recent quarters, with Q4 2026 EPS of $1.23 exceeding expectations. Valuation ratios include a P/E of 19.56 and P/S of 0.92, while the company maintains a 5.5% dividend yield, supported by positive cash flow trends and the Berry Global acquisition synergies.
Outlook is positive with analyst consensus favoring Buy (64.29%), a $47.00 price target, and projected revenue growth to $23.5B in 2026. Risks include debt levels and margin pressures, but defensive positioning and cost savings offer upside potential for income-focused investors.
Danaher (DHR) trades at $204.02, down 1.65% on the day, with a bullish technical outlook supported by moving averages and a recent history of earnings beats. The company maintains strong profitability margins and positive cash flow, though revenue growth has moderated. Recent news highlights product launches and a pending acquisition of Masimo, approved by shareholders in May 2026.
The stock presents a balanced outlook with solid fundamentals and analyst support, but faces risks from integration challenges and macroeconomic pressures. Upside is supported by a consensus price target of $202.33, while valuation multiples remain elevated relative to historical norms.
Trailing returns across standard periods
Latest headlines on both assets
Amcor is a global plastics packaging behemoth, with global sales of USD 14.5 billion in fiscal 2022 following the acquisition of Bemis in 2019. Amcor's operations span over 40 countries globally and include significant emerging-market exposure equating to circa 20% of sales. Amcor's capabilities span flexible and rigid plastic packaging, which sell into defensive food, beverage, healthcare, household, and personal-care end markets.
Read more on AMCR →In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →